Archive

Year: 2017

All Year: 2017 Articles

Newest first · Page 148

Halozyme Therapeutics Wins Big on Roche License Agreement

Halozyme Therapeutics saw its shares make a handy gain early on Thursday after the firm announced that it licensed its Enhanze drug-delivery technology to Roche for exclusive development of an “undisclosed therapeutic target.”

Chris Lange · 9 years ago

Amazon Slashes Prices on Fire Tablets

Amazon.com has marked down the price on its Fire tablets, which many analysts believe have never sold well. The deals target subscribers to Amazon's Prime service.

Douglas A. McIntyre · 9 years ago

6 Most Important Things in Business Today

Apple and Dell may bid for the Toshiba chips business, Boeing will increase production of its flagship Dreamliner, Saudi Arabia may delay its huge Aramco IPO, and more important headlines.

Douglas A. McIntyre · 9 years ago

Wednesday’s Biggest Winners and Losers in the S&P 500

Although the U.S. broad markets ended the day relatively flat, the S&P 500 touched a new all-time high even if just briefly. Also the DJIA and Nasdaq are also within points of their respective…

Chris Lange · 9 years ago

Can Retail Actually Grow Holiday Jobs This Year?

The strength of retail sales in the fourth quarter of each year is a benchmark for how well the U.S. consumer economy is doing. Over the past ten years, the number of jobs added…

Chris Lange · 9 years ago